Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma.
read more
Monday, December 23, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Wednesday, April 25, 2012
ISPE announced today that it has brought together a substantial line-up of global regulatory officials and pharmaceutical industry leaders to be plenary speakers at the FDA/ISPE co-sponsored “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md....
read more
FDA issued a guidance entitled, “Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Manufacturing.”
read more
Wednesday, August 24, 2022
GNS and Servier announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).
read more
Grand River Aseptic Manufacturing (GRAM) has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
read more
Grand River Aseptic Manufacturing (GRAM) completed its major $60 million expansion project and recently took occupancy.
read more
Monday, September 28, 2020
GRAM has entered into an agreement with Janssen to support the manufacture of its SARS-CoV-2 vaccine candidate.
read more
Grand River Aseptic Manufacturing has signed a multi-year contract with the U.S. Department of Health and Human Services and the U.S. Department of Defense. Under the agreement, GRAM will invest $160 million and receive $120 million from the U.S. ...
read more
Grand River Aseptic Manufacturing has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
read more
Thursday, November 07, 2019
Grand River Aseptic Manufacturing announced the addition of David Powell to its executive team.
read more
Grand River Aseptic Manufacturing ("GRAM"), a leading parenteral contract development and manufacturing organization, was recently ranked in Inc. Magazine's Inc. 5000 list for the third consecutive year.
read more
Wednesday, November 19, 2014
Grand River Aseptic Manufacturing (“GRAM”), a parenteral contract manufacturing organization supporting clinical through commercial cGMP manufacturing, has reached an exciting milestone by fully executing two commercial production contracts in one ...
read more